Newest first. 5.2k questions across 107 tags.
The case in front of me: 4 mg/mL · oral semaglutide. I would like the axes of comparison first and the recommendation second. I have tried the first option and it…
The case in front of me: aspartimide formation · liraglutide · 25 °C. I want to know whether this is a real physical effect or an artefact of how it is measured. What…
Conditions: semaglutide · 3.33 mg/mL · ten weeks. The claim is plausible, which is exactly why I want to check it. I am able to read a paper if someone points me at…
The case in front of me: semaglutide · Tianjin. The failure mode I am trying to avoid is making this decision emotionally. I have twelve months in view and I would…
The method section is present, which is unusual enough that I want to make use of it. I want to know whether this is a real physical effect or an artefact of how it…
For reference: peptide mapping · survodutide. The comparison I want does not seem to exist anywhere in a form I can evaluate. I have read the arguments for each and…
The specifics, since they change the answer: SURMOUNT-1 · survodutide. Somebody stated this to me confidently and I would like to check it before repeating it. I…
The specifics, since they change the answer: 8 mg/mL · ecnoglutide. The comparison I want does not seem to exist anywhere in a form I can evaluate. I have read the…
I have both a purity figure and a content figure, which is why the discrepancy is visible. I want to understand what this actually establishes, as opposed to what it…
For reference: 4 mg · 0.5 mL · phosphate-buffered diluent. I would rather understand the derivation than memorise the outcome. Two people I asked gave two answers…
The specifics, since they change the answer: GGPeps · semaglutide. I want to understand what this actually establishes, as opposed to what it is being used to imply.…
For reference: oral semaglutide · REDEFINE-1. I want to understand what this actually establishes, as opposed to what it is being used to imply. My concern is that I…
For reference: 99.1% · survodutide · JEEP. I would like to define my thresholds before I have a result, for obvious reasons. I want a plan with explicit stopping…
What I am working with: 96.4% · Medutest · 98.4%. This is not behaving the way I expected and I want to understand the discrepancy before I act on it. I have…
What I am working with: 20 mg · 1.5 mL · bacteriostatic water. I have worked this out and I would like someone to find the error, because I suspect there is one. My…
I am comparing a supplier certificate against an independent result on the same lot. Both of these get recommended confidently by different people, which suggests…
What I am working with: retatrutide · STEP 1. I would like help reading this properly rather than being told what conclusion to reach. I have the full report…
Stated plainly: orforglipron · 5 mg/mL. This is a procedural question rather than a theoretical one, and I would like the procedure rather than the theory. What I…
Setup, so nobody has to ask: SURMOUNT-2 · a GLP-1 receptor agonist. I would like help reading this properly rather than being told what conclusion to reach. I have…
Stated plainly: dulaglutide · eight weeks · 37 °C. I would like to set this up properly once, rather than adjust it repeatedly. My budget is real but not tight, and…
Numbers first: SWB · retatrutide. This is presented as though it settles something, and I am not convinced it does. I have two documents that appear to disagree,…
Details up front: 8 mg · 2 mL. I can do the algebra. I am not confident about the conversion factors. If there is a standard way to lay this out, I would rather learn…
Details up front: mazdutide · Xianning. I would rather over-plan the first cycle and simplify later. I am prepared to do the work if someone can tell me which work…
Concretely: PIONEER-1 · tirzepatide. The figures are clear enough; the question is what they mean and what they do not. I can supply the numbers if the specifics…